GPR52 regulates cAMP in T cells but is dispensable for encephalitogenic responses

G-protein coupled receptors (GPCR) regulate 3’,5’-cyclic adenosine monophosphate (cAMP) levels in T cells. cAMP as ubiquitous second messenger is crucial for adequate physiology of T cells by mediating effector T cell (Teff) function as well as regulatory T cell (Treg)-mediated immunosuppression. Se...

Full description

Bibliographic Details
Main Authors: Paula F. Krieg, Jana K. Sonner, Roberta Kurelic, Jan Broder Engler, Marlena F. Scharenberg, Simone Bauer, Viacheslav O. Nikolaev, Manuel A. Friese
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1113348/full
_version_ 1797944991198216192
author Paula F. Krieg
Jana K. Sonner
Roberta Kurelic
Jan Broder Engler
Marlena F. Scharenberg
Simone Bauer
Viacheslav O. Nikolaev
Manuel A. Friese
author_facet Paula F. Krieg
Jana K. Sonner
Roberta Kurelic
Jan Broder Engler
Marlena F. Scharenberg
Simone Bauer
Viacheslav O. Nikolaev
Manuel A. Friese
author_sort Paula F. Krieg
collection DOAJ
description G-protein coupled receptors (GPCR) regulate 3’,5’-cyclic adenosine monophosphate (cAMP) levels in T cells. cAMP as ubiquitous second messenger is crucial for adequate physiology of T cells by mediating effector T cell (Teff) function as well as regulatory T cell (Treg)-mediated immunosuppression. Several GPCRs have been identified to be crucial for Teff and Treg function. However, the role of the orphan, constitutively active Gs-coupled GPCR GPR52 is unknown. Here we show that GPR52 regulates cAMP levels in T cells but does not affect T cell function. We found that stimulation of transfected HEK cells or primary T cells with a GPR52 agonist results in a rise of intracellular cAMP. However, neither Gpr52 deficiency nor pharmacological modulation of GPR52 by antagonists or agonists affected T cell activation, differentiation, and proliferation or Treg-mediated immunosuppression. Moreover, Gpr52 deletion did not modify the clinical disease course of experimental autoimmune encephalomyelitis (EAE). Our results demonstrate that a modulation of cAMP levels in T cells does not inevitably result in altered T cell function. While we could not identify an obvious role of GPR52 in in vitro T cell assays and in vivo CNS autoimmunity, it might regulate T cell function in a different context or affect the function of other GPR52-expressing cells.
first_indexed 2024-04-10T20:47:13Z
format Article
id doaj.art-af0a257409994883bba763b26456c0a5
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-10T20:47:13Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-af0a257409994883bba763b26456c0a52023-01-24T06:27:29ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-01-011310.3389/fimmu.2022.11133481113348GPR52 regulates cAMP in T cells but is dispensable for encephalitogenic responsesPaula F. Krieg0Jana K. Sonner1Roberta Kurelic2Jan Broder Engler3Marlena F. Scharenberg4Simone Bauer5Viacheslav O. Nikolaev6Manuel A. Friese7Institute of Neuroimmunology and Multiple Sclerosis, Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyInstitute of Neuroimmunology and Multiple Sclerosis, Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyInstitute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyInstitute of Neuroimmunology and Multiple Sclerosis, Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyInstitute of Neuroimmunology and Multiple Sclerosis, Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyInstitute of Neuroimmunology and Multiple Sclerosis, Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyInstitute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyInstitute of Neuroimmunology and Multiple Sclerosis, Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyG-protein coupled receptors (GPCR) regulate 3’,5’-cyclic adenosine monophosphate (cAMP) levels in T cells. cAMP as ubiquitous second messenger is crucial for adequate physiology of T cells by mediating effector T cell (Teff) function as well as regulatory T cell (Treg)-mediated immunosuppression. Several GPCRs have been identified to be crucial for Teff and Treg function. However, the role of the orphan, constitutively active Gs-coupled GPCR GPR52 is unknown. Here we show that GPR52 regulates cAMP levels in T cells but does not affect T cell function. We found that stimulation of transfected HEK cells or primary T cells with a GPR52 agonist results in a rise of intracellular cAMP. However, neither Gpr52 deficiency nor pharmacological modulation of GPR52 by antagonists or agonists affected T cell activation, differentiation, and proliferation or Treg-mediated immunosuppression. Moreover, Gpr52 deletion did not modify the clinical disease course of experimental autoimmune encephalomyelitis (EAE). Our results demonstrate that a modulation of cAMP levels in T cells does not inevitably result in altered T cell function. While we could not identify an obvious role of GPR52 in in vitro T cell assays and in vivo CNS autoimmunity, it might regulate T cell function in a different context or affect the function of other GPR52-expressing cells.https://www.frontiersin.org/articles/10.3389/fimmu.2022.1113348/fullcAMPexperimental autoimmune encephalomyelitisFRETGPCRmultiple sclerosisT cells
spellingShingle Paula F. Krieg
Jana K. Sonner
Roberta Kurelic
Jan Broder Engler
Marlena F. Scharenberg
Simone Bauer
Viacheslav O. Nikolaev
Manuel A. Friese
GPR52 regulates cAMP in T cells but is dispensable for encephalitogenic responses
Frontiers in Immunology
cAMP
experimental autoimmune encephalomyelitis
FRET
GPCR
multiple sclerosis
T cells
title GPR52 regulates cAMP in T cells but is dispensable for encephalitogenic responses
title_full GPR52 regulates cAMP in T cells but is dispensable for encephalitogenic responses
title_fullStr GPR52 regulates cAMP in T cells but is dispensable for encephalitogenic responses
title_full_unstemmed GPR52 regulates cAMP in T cells but is dispensable for encephalitogenic responses
title_short GPR52 regulates cAMP in T cells but is dispensable for encephalitogenic responses
title_sort gpr52 regulates camp in t cells but is dispensable for encephalitogenic responses
topic cAMP
experimental autoimmune encephalomyelitis
FRET
GPCR
multiple sclerosis
T cells
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.1113348/full
work_keys_str_mv AT paulafkrieg gpr52regulatescampintcellsbutisdispensableforencephalitogenicresponses
AT janaksonner gpr52regulatescampintcellsbutisdispensableforencephalitogenicresponses
AT robertakurelic gpr52regulatescampintcellsbutisdispensableforencephalitogenicresponses
AT janbroderengler gpr52regulatescampintcellsbutisdispensableforencephalitogenicresponses
AT marlenafscharenberg gpr52regulatescampintcellsbutisdispensableforencephalitogenicresponses
AT simonebauer gpr52regulatescampintcellsbutisdispensableforencephalitogenicresponses
AT viacheslavonikolaev gpr52regulatescampintcellsbutisdispensableforencephalitogenicresponses
AT manuelafriese gpr52regulatescampintcellsbutisdispensableforencephalitogenicresponses